On May 20, 2021, an employee holds a vial of Sputnik V vaccine against coronavirus disease (COVID-19) manufactured on the basis of ingredients and technologies supplied by Russia at the Brazilian pharmaceutical company Uniao Quimica in Guarulhos.
Amanda Perobelli |
Russia has vehemently denied a new denial of allegations that Russian spies stole the “plan” of the Oxford-AstraZeneca vaccine and used it to create the Sputnik V.
This week, there were new reports in the British press that British security services had told British ministers that there was credible evidence that a Russian-made vaccine had been stolen and used to create the Sputnik V.
The Sun tabloid newspaper first reported the allegations made by British security services, but Downing Street declined to comment. This is not the first time Russia has been accused of trying to steal and corrupt Covid vaccine data, but Moscow has repeatedly denied the allegations, with the RDIF calling the latest report “fake” and “blatant lies.”
The head of the country’s sovereign wealth fund, the RDIF, echoed the idea on Wednesday, calling the allegations “scientific nonsense”.
“There is no reward [to these claims] We are very clear about this, ”Kirill Dmitriev said on Wednesday. – This report is absolutely scientific nonsense, it has no zero value and, frankly, it is a lie.
Dmitriev called the report “nonsense from unknown sources” and said the latest allegations were “because some politicians don’t like Russia and some major pharmaceutical companies are afraid of Sputnik V’s success.” continued to attack Sputnik V and Sputnik Light [its one-dose booster shot] from day one, so we’re used to these attacks, ”he said of“ Europe’s street signs ”.
Dmitriev noted that Sputnik V manufacturers want to partner with other vaccine manufacturers and conducted a clinical trial with AstraZeneca (to determine if mixed doses of Covid vaccine work), “we believe in a collaborative approach when working with other vaccines. Sputnik V is a partner of other vaccines. “
Russia is one of the world’s leading sovereign wealth funds with a direct investment fund, or RDIF, with $ 10 billion in reserve capital. The Foundation has supported the development of Russia’s main coronavirus vaccine – Sputnik V, which is the world’s first Covid vaccine – launched by Russia in August 2020.
The Sputnik V vaccine has raised doubts – primarily its clinical data and efficacy – and recent allegations about its origin and development.
An interim analysis of Phase 3 clinical trials involving 20,000 participants, published in The Lancet Medical Journal in early February, found that it was 91.6% effective against Covid-19 symptomatic infection.
However, the vaccine has not been approved for use by drug agencies in the United States, the United Kingdom, and the European Union. The World Health Organization said it was evaluating the vaccine, but did not indicate when and where it could provide an emergency use list.
Not to be outdone, Russia has developed several other vaccines against Covid and has since worked on a one-time vaccine called Sputnik Light, which is designed to shoot enhancers. In August, RDIF Sputnik Light proved to be “highly effective against Covid among more than 320,000 subjects who received the vaccine, based on data collected by July 30, 2021”. Its efficiency rate was 93.5%.
RDIF official Dmitriev said Russia expects the Sputnik V vaccine to be approved by the end of 2021 and hopes that the disposable Sputnik Light will soon be used as an enhancer along with other vaccines.
“We’ve seen a lot of positive signals from WHO recently, and they really appreciate what we’re doing … Sputnik Light can help other vaccines like AstraZeneca and Moderna, so we believe that. World Health Organization a positive solution with the organization, as early as the fall … of course we expect it to be approved soon, ”he said.